Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™ — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™ — Stella

Home/Mouth Diseases/

View on ClinicalTrials.gov

Recruiting

Back to Mouth Diseases trials

Trial locations(5 sites)

United States

The University of Alabama at Birmingham, Birmingham, Alabama

Loma Linda University, Loma Linda, California

Minnesota Oral and Facial Surgery, Minneapolis, Minnesota

MD Anderson Cancer Cetner, Houston, Texas

UTHealth Houston School of Dentistry, Houston, Texas

Key details

Sponsor

Proteocyte Diagnostics Inc.

Collaborators

The University of Texas Health Science Center, Houston, Loma Linda University

Enrollment target

~180 participants

Started

January 2023

Primary completion

December 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.